REVB (STOCKS)
Revelation Biosciences, Inc. Common Stock
$0.991100
-0.005200 (-0.52%)
Prev close: $0.996300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James M. Rolke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.87M
- Employees
- 9
- P/E (TTM)
- -0.03
- P/B (TTM)
- 0.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.71 | $-1.17 | -1.5370 | -131.03% |
|
Dec 2025 (Q4)
|
$-23.95 | $-3.73 | -20.2168 | -541.54% |
|
Sep 2025 (Q3)
|
$-7.08 | $-5.45 | -1.6332 | -29.98% |
|
Jun 2025 (Q2)
|
$-28.04 | $-18.18 | -9.8636 | -54.27% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $196.71K |
| Operating Expenses | $10.07M |
| Research and Development | $4.58M |
| Other Operating Expenses | $5.49M |
| Operating Income/Loss | -$10.07M |
| Income/Loss From Continuing Operations After Tax | -$9.87M |
| Income/Loss From Continuing Operations Before Tax | -$9.87M |
| Net Income/Loss | -$9.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $8.45M |
| Preferred Stock Dividends And Other Adjustments | $8.45M |
| Basic Earnings Per Share | -$25.68 |
| Diluted Earnings Per Share | -$25.68 |
| Basic Average Shares | 6,010,337 |
| Diluted Average Shares | 6,010,337 |
| Assets | $15.04M |
| Current Assets | $14.21M |
| Noncurrent Assets | $838.25K |
| Fixed Assets | $140.72K |
| Other Non-current Assets | $697.53K |
| Liabilities | $2.06M |
| Current Liabilities | $1.42M |
| Accounts Payable | $828.20K |
| Other Current Liabilities | $588.94K |
| Noncurrent Liabilities | $638.18K |
| Equity | $12.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.99M |
| Liabilities And Equity | $15.04M |
| Net Cash Flow From Operating Activities | -$8.69M |
| Net Cash Flow From Operating Activities, Continuing | -$8.69M |
| Net Cash Flow | $6.21M |
| Net Cash Flow, Continuing | $6.21M |
| Comprehensive Income/Loss | -$9.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.87M |
| Other Comprehensive Income/Loss | $0.00 |